Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,658
Closed -$254K 246
2025
Q4
$254K Buy
+5,658
New +$262K 0.13% 172
2025
Q3
Sell
-5,658
Closed -$272K 216
2025
Q2
$272K Hold
5,658
0.15% 154
2025
Q1
$227K Hold
5,658
0.13% 158
2024
Q4
$266K Buy
+5,658
New +$253K 0.15% 143

Other funds holding QGEN

Capital Square's QGEN Position: Q1 2026 in Review

Capital Square sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 5,658 shares — an estimated $254K sold.

Capital Square first reported a position in QGEN in Q4 2024 and held it in 4 quarters. The position peaked at $272K in Q2 2025. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Capital Square reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
  • Capital Square sold 5,658 Qiagen shares in Q1 2026, an estimated $254K.
  • Capital Square first reported a position in Qiagen in Q4 2024 and held it in 4 quarters.
  • Capital Square's Qiagen position peaked at $272K in Q2 2025.
  • 344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Capital Square's 13F filing for Q1 2026, filed 11 May 2026.